Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide in Metastatic Non-Small Cell Lung Cancer
NCT00006877Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Jul 2000
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in non-small cell lung cancer (NSCLC), sponsored by Case Comprehensive Cancer Center. Started Jul 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00006877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006877.